Regenerative Medicine in Ocular Surface: Application of Cell Therapy for Ocular Surface Repair Using Progenitor Cells of Sclerocorneal Limbus Amplified ex Vivo — MeRSO09  

Unilateral Limbic Insufficiency Clinical Trial

Official title: Regenerative Medicine in Ocular Surface: Application of Cell Therapy for Ocular Surface Repair Using Progenitor Autologous Cells of Sclerocorneal Limbus Amplified ex Vivo

Status Completed

Clinical Trial Summary

Progenitor limbo sclerocorneal cells have properties of proliferation and differentiation to corneal and conjunctival epithelium. This cells can be isolated and ex vivo expanded using cell culture technics that could permit the biological replacement of damaged ocular surface.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Unilateral Limbic Insufficiency

• NCT number: NCT01470573
• Study type: Interventional
• Source: Fundacion Clinic per a la Recerca Biomédica
• Status: Completed
• Phase: Phase 2
• Start date: November 2011
• Completion date: December 2012